#AIChem20posters Oxford Drug Design is presenting poster P48, "AIScape: a machine learning platform for activity and ADME predictions" at the 3rd @RSC_BMCS / @RSC_CICAG Artificial Intelligence in Chemistry virtual symposium on 28th-29th Sept #AIChem20#poster@jezwicker
Tb: Work-in-progress seminar by our PhD candiate @MarcoAlbanese93 discussed the discovery of compounds targeting bacterial two-componet systems.
Marco is doing his PhD as part of @OxDrugDes CARTNET project funded by EU's Horizon 2020 research.
There is an increase in antibiotic resistance which the world needs to address. I am proud to be working with @OxDrugDes. They are combining traditional approaches of drug design with #MachineLearning to find novel leads and candidates for drug resistant infections.
Meet ODD at the following conferences and events this spring!
1) Gordon Research Conference “Disruptive Antibiotics and non-Antibiotic Therapies to Combat Drug-Resistant Bacterial Infections” 1-6 March, Lucca, Italy https://t.co/M6A7bZGZ6j
We are delighted to announce that we have raised £2.2M in funding from @AngelCoFund, @o2hventures and other new investors, and grant funding from the @DHSCgovuk UK-China research competition, bringing our total raised in 2019 to over £9M! https://t.co/vUW8NqE4Li
Curious what else we did in #Riga? Check out the short blog post and some pictures of our handsome Phd students on our homepage!
https://t.co/yQEK6RlglK
#phdlife
@MSCActions
@EU_H2020
@RoySocChem What do you call a collection of quantum sheep? A Hartree-Flock!
Where would you find a quantum sheep? In a self-consistent field!
#InternationalJokeDay
We said our goodbyes to @anmolsadhav last week, so we now welcome another @CARTNET_itn researcher, Vitalii, for the next 5 weeks. Hope you enjoy your stay with us!
Oxford Drug Design has received nearly £2M in additional funding from the UK Department of Health and Social Care @DHSCgovuk for our tRNA synthetase #antibiotic project.
Oxford Drug Design is excited to announce the award of up to $2.55 million with the possibility of $4.24 million more from @CARB_X to continue the development of our tRNA synthetase inhibitor-based #antibiotics
https://t.co/aGZA5ygzHz
Just over a year since our last switch, we've expanded into an even larger office! Only across the hallway this time, no stairs required... and back to work already. Grateful to @anmolsadhav for his help. And thanks @OCFI_OI! #movingday@jezwicker@MarcoAlbanese93 @gracehcedmund